Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA) is a rare and progressive neurodegenerative disorder that affects the central and autonomic nervous systems, and can lead to a wide range of motor and non-motor symptoms. It is characterized by the slow degeneration of nerve cells, or neurons, in several areas of the brain. This leads to a loss of motor control and can cause severe disability, including paralysis and degenerative changes in the brain. MSA affects primarily adults between the ages of 40 and 60, and is more common in men than women. Although the cause of MSA is unknown, it is believed to result from a combination of environmental and genetic factors. MSA is a rare disorder and is estimated to affect fewer than one out of every 100,000 people. The primary symptoms of MSA are impaired balance, coordination and muscular control. Other non-motor symptoms can include urinary incontinence, constipation, sleep disturbances and dizziness. As the condition progresses, more severe symptoms may develop, including extreme parkinsonism, muscle weakness and wasting, and cognitive decline. Due to the progressive nature of MSA, it is considered a terminal illness with no known cure. Treatment for MSA focuses on managing symptoms and improving quality of life. Therapy and medications, such as physical therapy and anticholinergic drugs, are used to provide relief from motor and non-motor symptoms. In severe cases, surgery may be used to remove brain tissue to reduce the severity of symptoms. MSA is a rare disorder, but it is important to be aware of its symptoms and progression. Early diagnosis and treatment can help prolong quality of life and may slow the progression of the disease. If you have any concerns or think you may be at risk of MSA, it is important to speak to your doctor.